Fertility News and Research

RSS

Abnormal androgen signaling in ovaries cause female infertility

Male sex hormones, such as testosterone, have well defined roles in male reproduction and prostate cancer. What may surprise many is that they also play an important role in female fertility. A new study finds that the presence and activity of male sex hormones in the ovaries helps regulate female fertility, likely by controlling follicle growth and development and preventing deterioration of follicles that contain growing eggs.

27 May 2010

ART no longer part of free public health services in Denmark

In light of the need to prioritise public expenditure, the Danish goverment decided this month to implement a legislative amendment, so that Assisted Reproduction Treatment (ART) will no longer be part of the free public health services.

27 May 2010

Conceptual Options to conduct FREE seminar on Surrogacy, Embryo, Sperm and Egg Donation

The Surrogacy and Egg Donation Center, Conceptual Options, will be conducting a FREE seminar in Miami, Florida on the 17th and 18th of July 2010. These one-day FREE seminars will include a morning seminar and afternoon individual consultations. This seminar will focus on Surrogacy, Embryo, Sperm and Egg Donation and will be held at the Four Seasons resort in Miami, Florida.

26 May 2010

Carolina Conceptions receives IRB approval to study on new egg freezing technology

Carolina Conceptions, an infertility practice in Raleigh, NC, announces IRB approval to commence a study on egg freezing - a newer technology that is growing in demand. While embryo and sperm freezing have been the standard of care for decades, egg freezing has been slower to achieve the same level of success.

26 May 2010

Genentech to present new data for targeted cancer medicines at 46th ASCO

Genentech, Inc., a wholly owned member of the Roche Group, today announced that it will present new data for its targeted cancer medicines and the way they may be used in several different cancer types at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO). Approximately 400 abstracts featuring Genentech and Roche's cancer medicines and investigational agents across 30 cancer types will be presented during the meeting that is taking place June 4 to 8, 2010 in Chicago.

21 May 2010

Sex may become ‘old news’ when it comes to having babies says Australian scientist

According to researchers most couples over 30 will rely more on artificial methods to conceive. This prediction comes from John Yovich, Medical Director of Pivet Medical Centre, and a scientist acknowledged for his pioneering work in IVF, who calls human natural reproduction “a fairly inefficient process.”

18 May 2010

World Bank announces five-year plan to reduce maternal deaths, fertility rates in 58 low-income countries

During the release of its five-year plan to help drive down high maternal death and fertility rates in low-income countries, the World Bank on Tuesday said "that family planning and other reproductive health services have fallen off the radar of many governments, donors and aid agencies," Reuters reports.

13 May 2010

Ferring to acquire global rights to Xanodyne Pharmaceutical's LYSTEDA

Ferring Pharmaceuticals today announced an agreement that will expand its Women's Health product portfolio with the acquisition of the global rights to Xanodyne Pharmaceutical's LYSTEDA™ (tranexamic acid), a first-in-class, non-hormonal therapy indicated specifically for treatment of women with cyclic heavy menstrual bleeding (HMB).

10 May 2010

Social Security benefits play major role in leading older men to work longer: Study

The decline in the generosity of Social Security benefits for workers who recently reached their 60s has been the leading cause of the trend toward delayed retirement of older men, a new national study suggests.

5 May 2010

Merck reports non-GAAP EPS of $0.83 for first-quarter 2010

Merck & Co., Inc. today announced financial results for the first quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the first quarter of $0.83, which excludes purchase accounting adjustments, merger-related expenses and restructuring costs, as well as a tax charge related to the recently enacted health care reform legislation. First-quarter GAAP EPS was $0.09.

4 May 2010

LA BioMed receives $1.5M in grant to study contraceptive for men

As the birth control pill marks its 50th birthday this month, Los Angeles Biomedical Research Institute announced today that it has received $1.5 million in grant funding to study a contraceptive for men that uses a combination of two hormonal gels applied to the skin of the arm and abdomen.

4 May 2010

Cash crisis for infertility treatment prompting couples to go for multiple embryo implantations

With the rise in costs for fertility treatments, more and more Australian women are requesting their specialists to implant more than one embryo in their wombs. This is resulting in a rise in twin and triplet births.

3 May 2010

Foreign Policy examines global food security

One article, Robert Paarlberg, a professor of political science at Wellesley College, who has written a book about food security, argues that "[p]overty - caused by the low income productivity of farmers' labor - is the primary source of hunger in Africa, and the problem is only getting worse." Paarlberg writes about the need for "greater resources" to be put towards "farm technology, irrigation, and rural roads" in order to benefit small farmers in Africa.

3 May 2010

China Medical Technologies' AUTOMAGLIA 90 analyzer and Down Syndrome Screening receive SFDA approval

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic company, today announced that it received approval for its AUTOMAGLIA 90 fully-automated ECLIA analyzer as well as Down Syndrome screening kit from the State Food and Drug Administration of China.

29 Apr 2010

Takeda announces submission of azilsartan medoxomil NDA for hypertension to FDA

Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB) under investigation for the treatment of hypertension. Discovered by Takeda, azilsartan medoxomil is designed to lower blood pressure by blocking the action of a vasopressor hormone, angiotensin II.

28 Apr 2010

Reluctant Australian sperm donors forces fertility clinics to import from U.S.

With the shortage of sperm donors the Queensland Fertility Group, the largest fertility facility in Townsville has resorted to importing sperm from United States. This facility, some 1,300 Kilometers from Brisbane is reportedly paying $700-800 an ampule for the imported sperm. This is a new situation. Earlier the facility had a large number of donors of which a huge number were the university students but there has been a steady decline in donors with many north Queensland men, or even Australian men who are not prepared to donate.

27 Apr 2010

IntegraMed America's Vein Clinics business grows 20% in first-quarter 2010

IntegraMed America, Inc., the leader in developing and managing specialty healthcare facilities in the fertility and vein care markets, today announced strong results for the first quarter ended March 31, 2010.

27 Apr 2010

Opinions: G8 summit; World Malaria Day; Family planning; Global Food Security Act

As G8 development leaders gather in Halifax, Nova Scotia, this week to discuss priorities for the upcoming summit, Josette Sheeran, executive director of the WFP, calls for world leaders to focus on the nutritional needs of mothers and children in developing countries in a Toronto Star opinion piece.

27 Apr 2010

Increase in number of mistakes made at fertility clinics

For many couples IVF is the last hope they have of having a baby and with some IVF clinics committing such blunders as implanting the wrong embryos or fertilizing the egg with the wrong man’s sperm, these hope can soon turn into a nightmare.

26 Apr 2010

Merck to market and distribute MBL's Td vaccine in the U.S.

MassBiologics of the University of Massachusetts Medical School and Merck & Co., Inc. announced today that they have entered into an agreement that provides Merck with exclusive rights to market and distribute MBL's tetanus and diphtheria toxoids adsorbed (Td) vaccine in the United States, with the exception of Massachusetts, where MBL will continue distributing the vaccine.

21 Apr 2010

Fertility News and Research

Abnormal androgen signaling in ovaries cause female infertility

ART no longer part of free public health services in Denmark

Conceptual Options to conduct FREE seminar on Surrogacy, Embryo, Sperm and Egg Donation

Carolina Conceptions receives IRB approval to study on new egg freezing technology

Genentech to present new data for targeted cancer medicines at 46th ASCO

Sex may become ‘old news’ when it comes to having babies says Australian scientist

World Bank announces five-year plan to reduce maternal deaths, fertility rates in 58 low-income countries

Ferring to acquire global rights to Xanodyne Pharmaceutical's LYSTEDA

Social Security benefits play major role in leading older men to work longer: Study

Merck reports non-GAAP EPS of $0.83 for first-quarter 2010

LA BioMed receives $1.5M in grant to study contraceptive for men

Cash crisis for infertility treatment prompting couples to go for multiple embryo implantations

Foreign Policy examines global food security

China Medical Technologies' AUTOMAGLIA 90 analyzer and Down Syndrome Screening receive SFDA approval

Takeda announces submission of azilsartan medoxomil NDA for hypertension to FDA

Reluctant Australian sperm donors forces fertility clinics to import from U.S.

IntegraMed America's Vein Clinics business grows 20% in first-quarter 2010

Opinions: G8 summit; World Malaria Day; Family planning; Global Food Security Act

Increase in number of mistakes made at fertility clinics

Merck to market and distribute MBL's Td vaccine in the U.S.

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News